Eton Pharmaceuticals, Inc. (ETON)
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $80.0M
- Net income
- -$4.6M
- Total assets
- $92.1M
- Market cap
- $797.9M
- Gross margin
- 53.5%
- Operating margin
- -1.1%
- Net margin
- -5.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $80.0M
- Cost of revenue
- $37.2M
- Gross profit
- $42.7M
- Operating expenses
- $43.6M
- Operating income
- -$844.0K
- Income tax
- $43.0K
- Net income
- -$4.6M
- EPS (basic)
- $-0.17
Balance sheet
- Total assets
- $92.1M
- Current assets
- $60.6M
- Total liabilities
- $66.0M
- Current liabilities
- $38.5M
- Shareholders’ equity
- $26.2M
Cash flow
- Operating cash flow
- $10.5M
- Investing cash flow
- -$333.0K
- Financing cash flow
- $815.0K
- Net cash flow
- $11.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $797.9M
- Shares outstanding
- 18.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 14, 2018
Eton Pharmaceuticals, Inc. (ETON) Stock Price
- Reported a net loss of $4.6M in FY2025.
- Revenue grew 266% from FY2021 to FY2025.
- Gross margin of 53.5%, net margin -5.8%.
- Trading 4% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Eton Pharmaceuticals, Inc..
Write a review
News about Eton Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Eton Pharmaceuticals, Inc.: frequently asked questions
Is Eton Pharmaceuticals, Inc. an American company?
Eton Pharmaceuticals, Inc. is a US-based company headquartered in Deer Park, Illinois, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Eton Pharmaceuticals, Inc. headquartered?
Eton Pharmaceuticals, Inc. is headquartered in Deer Park, Illinois, United States.
Is Eton Pharmaceuticals, Inc. publicly traded?
Yes — Eton Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ETON on the NASDAQ.
What does Eton Pharmaceuticals, Inc. do?
Eton Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
